Cohance Lifesciences Ltd shares dropped over 5% after reports said promoter Jusmiral Holdings plans to sell a 5.1% stake via block deals. The transaction is valued at ₹1,756 crore with a floor price of ₹900 per share, sparking investor concerns and weighing on the stock in today's trade.